Ikarian Capital, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$735.3B
Holdings
147
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (147 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XBISPDR SER TR | 1,450,000 | $130.6B | 17.76% | Put |
| 2 | TSNTYSON FOODS INC | 630,000 | $36.2B | 4.92% | Put |
| 3 | TARSTARSUS PHARMACEUTICALS INC | 607,689 | $33.6B | 4.58% | |
| 4 | CRNXCRINETICS PHARMACEUTICALS IN | 516,431 | $26.4B | 3.59% | |
| 5 | BBIOBRIDGEBIO PHARMA INC | 915,713 | $25.1B | 3.42% | Call |
| 6 | SRRKSCHOLAR ROCK HLDG CORP | 459,285 | $19.9B | 2.70% | Call |
| 7 | AMGNAMGEN INC | 74,000 | $19.3B | 2.62% | Call |
| 8 | IM8NINSMED INC | 269,800 | $18.6B | 2.53% | Call |
| 9 | 2L9BLUEPRINT MEDICINES CORP | 169,374 | $14.8B | 2.01% | |
| 10 | RNAAVIDITY BIOSCIENCES INC | 500,000 | $14.5B | 1.98% | Put |
| 11 | SRPTSAREPTA THERAPEUTICS INC | 115,087 | $14.0B | 1.90% | Call |
| 12 | FBRXFORTE BIOSCIENCES INC | 609,225 | $13.8B | 1.88% | |
| 13 | PPCPILGRIMS PRIDE CORP | 300,000 | $13.6B | 1.85% | Put |
| 14 | NMRANEUMORA THERAPEUTICS INC. | 1,250,000 | $13.3B | 1.80% | Put |
| 15 | VRDNVIRIDIAN THERAPEUTICS INC | 645,049 | $12.4B | 1.68% | Call |
| 16 | VIRVIR BIOTECHNOLOGY INC | 1,618,162 | $11.9B | 1.62% | Call |
| 17 | CAPRCAPRICOR THERAPEUTICS INC | 661,100 | $9.1B | 1.24% | Put |
| 18 | ELVNENLIVEN THERAPEUTICS INC | 394,538 | $8.9B | 1.21% | |
| 19 | TGTXTG THERAPEUTICS INC | 291,240 | $8.8B | 1.19% | |
| 20 | AXSMAXSOME THERAPEUTICS INC | 100,000 | $8.5B | 1.15% | Call |
| 21 | RCUSARCUS BIOSCIENCES INC | 519,363 | $7.7B | 1.05% | Call |
| 22 | CALMCAL MAINE FOODS INC | 75,000 | $7.7B | 1.05% | Put |
| 23 | GPCRSTRUCTURE THERAPEUTICS INC | 284,085 | $7.7B | 1.05% | |
| 24 | DNAGINKGO BIOWORKS HOLDINGS INC | 769,700 | $7.6B | 1.03% | Call |
| 25 | RAREULTRAGENYX PHARMACEUTICAL IN | 178,989 | $7.5B | 1.02% | |
| 26 | IMVTIMMUNOVANT INC | 300,600 | $7.4B | 1.01% | Call |
| 27 | ANABANAPTYSBIO INC | 560,800 | $7.4B | 1.01% | Put |
| 28 | CPRXCATALYST PHARMACEUTICALS INC | 349,649 | $7.3B | 0.99% | |
| 29 | AVTXAVALO THERAPEUTICS INC | 970,259 | $7.2B | 0.98% | |
| 30 | CYTKCYTOKINETICS INC | 149,982 | $7.1B | 0.96% | |
| 31 | CRVSCORVUS PHARMACEUTICALS INC | 1,254,400 | $6.7B | 0.91% | Put |
| 32 | DYNDYNE THERAPEUTICS INC | 280,800 | $6.6B | 0.90% | Put |
| 33 | TECXTECTONIC THERAPEUTIC INC | 142,328 | $6.6B | 0.89% | |
| 34 | SYRESPYRE THERAPEUTICS INC | 282,159 | $6.6B | 0.89% | |
| 35 | KODKODIAK SCIENCES INC | 576,166 | $5.7B | 0.78% | |
| 36 | AKROAKERO THERAPEUTICS INC | 199,000 | $5.5B | 0.75% | Put |
| 37 | ONCBEIGENE LTD | 29,800 | $5.5B | 0.75% | Call |
| 38 | DRUGBRIGHT MINDS BIOSCIENCES INC | 152,211 | $5.5B | 0.75% | |
| 39 | TCE2CELLDEX THERAPEUTICS INC NEW | 205,500 | $5.2B | 0.71% | Put |
| 40 | ELDNELEDON PHARMACEUTICALS INC | 1,126,637 | $4.6B | 0.63% | |
| 41 | ACOGALPHA COGNITION INC | 755,867 | $4.5B | 0.61% | |
| 42 | LENZLENZ THERAPEUTICS INC | 149,502 | $4.3B | 0.59% | |
| 43 | RZLTREZOLUTE INC | 857,230 | $4.2B | 0.57% | |
| 44 | MRNAMODERNA INC | 100,000 | $4.2B | 0.57% | Put |
| 45 | EOLSEVOLUS INC | 373,265 | $4.1B | 0.56% | |
| 46 | MLYSMINERALYS THERAPEUTICS INC | 332,390 | $4.1B | 0.56% | |
| 47 | NUVLNUVALENT INC | 52,216 | $4.1B | 0.56% | |
| 48 | JANXJANUX THERAPEUTICS INC | 74,691 | $4.0B | 0.54% | |
| 49 | VRNAVERONA PHARMA PLC | 80,000 | $3.7B | 0.51% | |
| 50 | HELPCYBIN INC | 397,175 | $3.5B | 0.48% | |
| 51 | ARCTARCTURUS THERAPEUTICS HLDGS | 200,000 | $3.4B | 0.46% | |
| 52 | SLNOSOLENO THERAPEUTICS INC | 75,000 | $3.4B | 0.46% | Put |
| 53 | ABEOABEONA THERAPEUTICS INC | 598,581 | $3.3B | 0.45% | Call |
| 54 | LXEOLEXEO THERAPEUTICS INC | 499,301 | $3.3B | 0.45% | |
| 55 | PHPNGALECTIN THERAPEUTICS INC | 2,400,100 | $3.1B | 0.42% | Put |
| 56 | RLAYRELAY THERAPEUTICS INC | 693,308 | $2.9B | 0.39% | |
| 57 | RCKTROCKET PHARMACEUTICALS INC | 221,911 | $2.8B | 0.38% | |
| 58 | PTGXPROTAGONIST THERAPEUTICS INC | 70,000 | $2.7B | 0.37% | |
| 59 | ALGSALIGOS THERAPEUTICS INC | 64,300 | $2.6B | 0.35% | |
| 60 | SANASANA BIOTECHNOLOGY INC | 1,515,000 | $2.5B | 0.34% | Put |
| 61 | ZVRAZEVRA THERAPEUTICS INC | 292,772 | $2.4B | 0.33% | |
| 62 | XENEXENON PHARMACEUTICALS INC | 62,052 | $2.4B | 0.33% | |
| 63 | NVV1NOVAVAX INC | 300,000 | $2.4B | 0.33% | Call |
| 64 | VTYXVENTYX BIOSCIENCES INC | 1,092,590 | $2.4B | 0.33% | |
| 65 | ALTALTIMMUNE INC | 331,400 | $2.4B | 0.32% | Put |
| 66 | IMUXIMMUNIC INC | 2,249,970 | $2.2B | 0.31% | Call |
| 67 | TEVATEVA PHARMACEUTICAL INDS LTD | 100,000 | $2.2B | 0.30% | Call |
| 68 | OKURONKURE THERAPEUTICS INC | 253,754 | $2.2B | 0.30% | |
| 69 | GLUEMONTE ROSA THERAPEUTICS INC | 311,575 | $2.2B | 0.29% | |
| 70 | SLRNACELYRIN INC | 676,608 | $2.1B | 0.29% | |
| 71 | HROWHARROW INC | 58,300 | $2.0B | 0.27% | Call |
| 72 | CRDFCARDIFF ONCOLOGY INC | 450,000 | $2.0B | 0.27% | |
| 73 | GBYSANGAMO THERAPEUTICS INC | 1,860,179 | $1.9B | 0.26% | |
| 74 | NKTREURNEKTAR THERAPEUTICS | 2,029,028 | $1.9B | 0.26% | |
| 75 | TARAPROTARA THERAPEUTICS INC | 350,489 | $1.9B | 0.25% | |
| 76 | ALECALECTOR INC | 950,000 | $1.8B | 0.24% | |
| 77 | TERNTERNS PHARMACEUTICALS INC | 308,491 | $1.7B | 0.23% | |
| 78 | BMEABIOMEA FUSION INC | 431,100 | $1.7B | 0.23% | Put |
| 79 | 698ACHILLES THERAPEUTICS PLC | 1,441,141 | $1.6B | 0.22% | |
| 80 | ANROALTO NEUROSCIENCE INC | 350,000 | $1.5B | 0.20% | |
| 81 | IBIOIBIO INC | 599,913 | $1.5B | 0.20% | |
| 82 | CDTXCIDARA THERAPEUTICS INC | 53,940 | $1.4B | 0.20% | |
| 83 | TRMLTOURMALINE BIO INC | 67,927 | $1.4B | 0.19% | |
| 84 | SWTXSPRINGWORKS THERAPEUTICS INC | 37,519 | $1.4B | 0.18% | |
| 85 | TRVITREVI THERAPEUTICS INC | 325,000 | $1.3B | 0.18% | |
| 86 | DCTHDELCATH SYS INC | 100,365 | $1.2B | 0.16% | |
| 87 | SLDBSOLID BIOSCIENCES INC | 300,000 | $1.2B | 0.16% | Call |
| 88 | JSPRJASPER THERAPEUTICS INC | 55,107 | $1.2B | 0.16% | |
| 89 | ALLKGUSDALLAKOS INC | 971,950 | $1.2B | 0.16% | |
| 90 | LXRXLEXICON PHARMACEUTICALS INC | 1,550,000 | $1.1B | 0.16% | |
| 91 | MISTMILESTONE PHARMACEUTICALS IN | 466,030 | $1.1B | 0.15% | |
| 92 | THRDTHIRD HARMONIC BIO INC | 100,000 | $1.0B | 0.14% | |
| 93 | VERVVERVE THERAPEUTICS INC | 169,991 | $958.7M | 0.13% | |
| 94 | PYXSPYXIS ONCOLOGY INC | 613,253 | $956.7M | 0.13% | |
| 95 | FULCFULCRUM THERAPEUTICS INC | 200,096 | $940.5M | 0.13% | |
| 96 | RNACCARTESIAN THERAPEUTICS INC | 52,166 | $934.3M | 0.13% | |
| 97 | TRAWTRAWS PHARMA INC | 98,493 | $874.6M | 0.12% | |
| 98 | ACRSACLARIS THERAPEUTICS INC | 350,000 | $868.0M | 0.12% | |
| 99 | VIGLVIGIL NEUROSCIENCE INC | 500,000 | $850.0M | 0.12% | |
| 100 | TYRATYRA BIOSCIENCES INC | 60,000 | $834.0M | 0.11% |
Page 1 of 2Next